ATRA is effective to an acute promyelocytic leukemia patient without RARA gene rearrangement.
Song
Xianmin
X
Gong
Shenglan
S
Chen
Jie
J
Gao
Lei
L
Yang
Jianmin
J
Wang
Jianmin
J
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D015321:Gene Rearrangement; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D018168:Receptors, Retinoic Acid / Q000235:genetics*; D016896:Treatment Outcome; D014212:Tretinoin / Q000627:therapeutic use*; D055815:Young Adult
D000970:Antineoplastic Agents; D018168:Receptors, Retinoic Acid; D014212:Tretinoin